Drug
Daunorubicin Hydrochloride
Important: Reactions below are the flagged terms from this drug’s
FAERS report history (min. 3 co-reports per term) — PRR/ROR indicate
disproportionality in spontaneous reporting, not causation.
Data from FDA FAERS via openFDA. Last recalculated: 2026-09-14.
| Reaction | Co-reports (a) | PRR | ROR | Signal | |
|---|---|---|---|---|---|
| 1 | Clostridium Difficile Colitis | 110 | 138.9 | 149.2 | signal |
| 2 | Bacterial Infection | 154 | 111.0 | 122.8 | signal |
| 3 | Myelosuppression | 161 | 63.1 | 70.1 | signal |
| 4 | Lymphopenia | 59 | 55.9 | 58.0 | signal |
| 5 | Bone Marrow Failure | 61 | 39.7 | 41.2 | signal |
| 6 | Febrile Neutropenia | 194 | 39.0 | 44.3 | signal |
| 7 | Fungal Infection | 87 | 34.8 | 36.7 | signal |
| 8 | Viral Infection | 86 | 34.4 | 36.3 | signal |
| 9 | Hyperbilirubinaemia | 21 | 27.1 | 27.5 | signal |
| 10 | Posterior Reversible Encephalopathy Syndrome | 19 | 26.5 | 26.9 | signal |
| 11 | Acute Myeloid Leukaemia | 31 | 26.5 | 27.0 | signal |
| 12 | Bacteraemia | 20 | 22.6 | 22.9 | signal |
| 13 | Pancytopenia | 92 | 21.9 | 23.2 | signal |
| 14 | Lymphadenopathy | 48 | 18.0 | 18.5 | signal |
| 15 | Disseminated Intravascular Coagulation | 19 | 17.9 | 18.1 | signal |
| 16 | Oral Herpes | 26 | 17.8 | 18.0 | signal |
| 17 | Electrolyte Imbalance | 15 | 17.3 | 17.5 | signal |
| 18 | Device Related Infection | 20 | 17.2 | 17.4 | signal |
| 19 | Coagulopathy | 21 | 16.8 | 17.0 | signal |
| 20 | Polyneuropathy | 15 | 16.8 | 16.9 | signal |
| 21 | Mucosal Inflammation | 32 | 16.3 | 16.6 | signal |
| 22 | Premature Delivery | 19 | 15.8 | 16.0 | signal |
| 23 | Hepatotoxicity | 25 | 15.0 | 15.2 | signal |
| 24 | Septic Shock | 48 | 14.8 | 15.2 | signal |
| 25 | Cytomegalovirus Infection | 18 | 14.4 | 14.5 | signal |
| 26 | Incorrect Route Of Product Administration | 18 | 14.2 | 14.4 | signal |
| 27 | Cellulitis | 54 | 14.2 | 14.7 | signal |
| 28 | Tooth Infection | 14 | 14.1 | 14.2 | signal |
| 29 | Ileus | 13 | 14.0 | 14.1 | signal |
| 30 | Myelodysplastic Syndrome | 15 | 13.8 | 13.9 | signal |
| 31 | Drug Resistance | 23 | 11.9 | 12.1 | signal |
| 32 | Neutrophil Count Decreased | 36 | 11.8 | 12.1 | signal |
| 33 | Acute Respiratory Distress Syndrome | 15 | 11.3 | 11.4 | signal |
| 34 | Multiple Organ Dysfunction Syndrome | 23 | 10.9 | 11.1 | signal |
| 35 | Circulatory Collapse | 14 | 10.9 | 11.0 | signal |
| 36 | Blood Bilirubin Increased | 22 | 10.8 | 10.9 | signal |
| 37 | Cystitis | 25 | 10.4 | 10.5 | signal |
| 38 | Agranulocytosis | 14 | 10.1 | 10.1 | signal |
| 39 | Cardiomyopathy | 11 | 9.9 | 9.9 | signal |
| 40 | Colitis | 27 | 9.5 | 9.7 | signal |
| 41 | Neoplasm Progression | 25 | 9.5 | 9.6 | signal |
| 42 | Musculoskeletal Chest Pain | 11 | 9.4 | 9.5 | signal |
| 43 | Blood Lactate Dehydrogenase Increased | 11 | 9.2 | 9.2 | signal |
| 44 | Pancreatitis Acute | 15 | 8.9 | 9.0 | signal |
| 45 | Cytopenia | 8 | 8.9 | 8.9 | signal |
| 46 | Adrenal Insufficiency | 8 | 8.9 | 8.9 | signal |
| 47 | Clostridium Difficile Infection | 14 | 8.6 | 8.6 | signal |
| 48 | Ejection Fraction Decreased | 10 | 8.5 | 8.6 | signal |
| 49 | Premature Baby | 19 | 8.4 | 8.4 | signal |
| 50 | Temperature Intolerance | 6 | 7.8 | 7.8 | signal |
| 51 | Respiratory Failure | 42 | 7.6 | 7.8 | signal |
| 52 | Ventricular Tachycardia | 9 | 7.2 | 7.2 | signal |
| 53 | Platelet Count Decreased | 55 | 6.9 | 7.1 | signal |
| 54 | Multi-organ Failure | 9 | 6.8 | 6.8 | signal |
| 55 | Neutropenia | 69 | 6.8 | 7.0 | signal |
| 56 | White Blood Cell Count Decreased | 53 | 6.5 | 6.7 | signal |
| 57 | Hepatic Function Abnormal | 18 | 6.4 | 6.5 | signal |
| 58 | Shock | 11 | 6.4 | 6.4 | signal |
| 59 | Thrombocytopenia | 52 | 6.2 | 6.4 | signal |
| 60 | Haematotoxicity | 4 | 5.7 | 5.7 | signal |
| 61 | Hepatic Encephalopathy | 4 | 5.7 | 5.7 | signal |
| 62 | Grand Mal Convulsion | 4 | 5.7 | 5.7 | signal |
| 63 | Thrombotic Microangiopathy | 4 | 5.5 | 5.5 | signal |
| 64 | Inappropriate Antidiuretic Hormone Secretion | 4 | 5.2 | 5.2 | signal |
| 65 | Lung Infection | 6 | 5.1 | 5.1 | signal |
| 66 | Face Oedema | 6 | 4.7 | 4.7 | signal |
| 67 | Exposure During Pregnancy | 22 | 4.7 | 4.7 | signal |
| 68 | Status Epilepticus | 4 | 4.7 | 4.7 | signal |
| 69 | Myocarditis | 4 | 4.7 | 4.7 | signal |
| 70 | Pneumocystis Jirovecii Pneumonia | 3 | 4.0 | 4.0 | signal |
| 71 | Neurotoxicity | 5 | 3.8 | 3.8 | signal |
| 72 | Hepatocellular Injury | 4 | 3.7 | 3.7 | signal |
| 73 | Nephropathy Toxic | 3 | 3.6 | 3.6 | no signal |
| 74 | Haemorrhage Intracranial | 4 | 3.5 | 3.5 | signal |
| 75 | Malignant Neoplasm Progression | 24 | 3.1 | 3.2 | signal |
| 76 | Foetal Exposure During Pregnancy | 18 | 2.9 | 3.0 | signal |
| 77 | Drug Reaction With Eosinophilia And Systemic Symptoms | 5 | 2.6 | 2.6 | no signal |